AMOEBA (EPA:ALMIB) | Finanzwire

Basculer en Français

10372	Companies
216173	Keywords
145882	Articles
114461	Press releases

Home
Companies
AMOEBA

PRESS RELEASE

published on 05/20/2025 at 19:00, 11 months 20 days ago

Amoéba announces the nomination of Charlotte Franceries, a leading figure in the cosmetics and communications industry, to its Board of Directors
Amoéba announces the proposed appointment of Charlotte Franceries as a member of its Board of Directors, bringing extensive expertise from the cosmetics industry

AMOEBA Board Of Directors Appointment Cosmetics Industry Charlotte Franceries
BRIEF

published on 05/12/2025 at 18:05, 11 months 28 days ago

Amoéba and Koppert in final phase before the launch of AXPERA

Biocontrol Agricultural Innovation Authorizations AXPERA Launch Amoéba Koppert
PRESS RELEASE

published on 05/12/2025 at 18:00, 11 months 28 days ago

Amoéba and Koppert continue to prepare the commercial launch of AXPERA, the biocontrol product developed by Amoéba.
Amoéba to continue preparing for commercial launch of biocontrol solution AXPERA with Koppert, following successful authorisations. Company aims to meet market expectations for innovative biocontrol solutions

AMOEBA Biocontrol Commercial Launch AXPERA Koppert
BRIEF

published on 05/06/2025 at 08:05, 1 year ago

Amoéba obtains an exemption in the Netherlands for AXPERA

AMOEBA Biocontrol Authorisation AXPERA The Netherlands
PRESS RELEASE

published on 05/06/2025 at 08:00, 1 year ago

Amoéba obtains an exceptional exemption in the Netherlands for its biocontrol product AXPERA for large-scale greenhouse trials
Amoéba obtained authorisation for trials of AXPERA in the Netherlands, allowing consumption of treated crops. The Dutch greenhouse market is a strategic showcase for showcasing AXPERA's value in biocontrol fungicide

AMOEBA Biocontrol Netherlands AXPERA Greenhouse Market
BRIEF

published on 04/22/2025 at 18:05, 1 year ago

Emergency authorization for Amoéba's AXPERA product in France

AMOEBA Biocontrol AXPERA Vine Mildew Emergency Authorization
PRESS RELEASE

published on 04/22/2025 at 18:00, 1 year ago

New strategic milestone for Amoéba: Axpéra biocontrol product receives emergency market authorisation in France // A proven new solution to help winegrowers combat grapevine downy mildew
Amoéba receives emergency marketing authorization for AXPERA biocontrol product to combat grapevine downy mildew, helping French winegrowers against phytosanitary challenges

AMOEBA Biocontrol AXPERA Emergency Authorization Grapevine Downy Mildew
BRIEF

published on 04/17/2025 at 18:05, 1 year ago

Amoéba publishes its 2024 Universal Registration Document

AMOEBA AMF Financial Report Corporate Governance Registration Document
PRESS RELEASE

published on 04/17/2025 at 18:00, 1 year ago

Amoéba announces the publication of its Universal Registration Document 2024
Amoéba announces filing of 2024 Universal Registration Document with French Financial Markets Authority, including financial reports and corporate governance details

AMOEBA French Financial Markets Authority GreenTech Microbiological Solutions 2024 Universal Registration Document
BRIEF

published on 04/14/2025 at 08:50, 1 year ago

AMOEBA: Initiation of Coverage by KBC Securities and International Expansion

AMOEBA International Biocontrol Cosmetic KBC Securities

Accesswire

Published on 05/09/2026 at 01:55, 1 day 9 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day 9 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day 9 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 11 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 1 day 12 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/09/2026 at 19:05, 16 hours 2 minutes ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 14 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 15 hours ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 16 hours ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 1 day 16 hours ago

Designated Person Notification

Les Echos

Published on 05/07/2026 at 19:15, 2 days 15 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 2 days 16 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 2 days 16 hours ago

DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 18:12, 2 days 16 hours ago

LNA SANTE : Q1 2026
Published on 05/07/2026 at 17:45, 2 days 17 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE